Showing results (221-230 of 243) with videos related to

Sort By:
Pageof 25
Current Oncology (Toronto, Ont.)|July 10, 2019
Initial management of small-cell lung cancer (limited- and extensive-stage) and the role of thoracic radiotherapy and first-line chemotherapy: a systematic reviewA Sun, L D Durocher-Allen, P M Ellis, et al.
Bioorganic & Medicinal Chemistry Letters|July 30, 2005
Structure-activity relationships of Erwinia carotovora quorum sensing signaling moleculesMartin Welch, Jenny M Dutton, Freija G Glansdorp, et al.
Current Oncology (Toronto, Ont.)|July 10, 2019
Surgery after chemoradiotherapy in patients with stage III (N2 or N3, excluding T4) non-small-cell lung cancer: a systematic reviewA Swaminath, E T Vella, K Ramchandar, et al.
Medical Education|September 1, 1993
The oral examination: a study of academic and non-academic factorsC S Thomas, G Mellsop, K Callender, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1996
On the receiving end. V: Patient perceptions of the side effects of cancer chemotherapy in 1993A M Griffin, P N Butow, A S Coates, et al.
Organic & Biomolecular Chemistry|October 2, 2010
Discovery of a quorum sensing modulator pharmacophore by 3D small-molecule microarray screeningDavid M Marsden, Rebecca L Nicholson, Mette E Skindersoe, et al.
Molecular Microbiology|January 22, 2005
Carbapenem antibiotic biosynthesis in Erwinia carotovora is regulated by physiological and genetic factors modulating the quorum sensing-dependent control pathwaySimon J McGowan, Anne M L Barnard, Gulgun Bosgelmez, et al.
The Australian and New Zealand Journal of Psychiatry|September 1, 1994
Staffing and funding of consultation-liaison psychiatry services in Australia and New ZealandG C Smith, P M Ellis, V J Carr, et al.
Plos Pathogens|June 21, 2008
Quorum sensing coordinates brute force and stealth modes of infection in the plant pathogen Pectobacterium atrosepticumHui Liu, Sarah J Coulthurst, Leighton Pritchard, et al.
Current Oncology (Toronto, Ont.)|February 21, 2009
The role of the epidermal growth factor receptor tyrosine kinase inhibitors as therapy for advanced, metastatic, and recurrent non-small-cell lung cancer: a Canadian national consensus statementP M Ellis, W Morzycki, B Melosky, et al.
Pageof 25